Logo

Greiner Bio-One Licenses Invitrogen's PCR Sample-Prep Tech for HPV Test

Jun 25, 2007
NEW YORK (GenomeWeb News) – Greiner Bio-One has licensed Invitrogen’s deoxyuridine triphosphate technology for use in a PCR-based HPV test and in DNA array products, the companies said today.
 
Greiner Bio-One said it will use dUTP in place of deoxythymidine triphosphate to prevent false positives during PCR by reducing sample contamination.
 
The company said the use of dUTP will improve the reliability of its PapilloCheck HPV test and its DNA-array CytoCheck products. Greiner Bio-One will begin offering product kits for PapilloCheck with dUTP in June, and plans to offer dUTP-based kits for CytoCheck this fall.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.